K-numberK250253
Device nameIPL Hair Removal Device (KCA511/KCA516/KCA522)
ApplicantDongguan Boyuan Intelligent Technology Co.,Ltd
Product codeOHT
Device classClass II
Decision dateMay 6, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The IPL Hair Removal Device (models KCA511, KCA516, KCA522) is an over-the-counter, home-use device that removes unwanted hair using intense pulsed light (IPL) energy. It is indicated for hair removal and permanent reduction in hair regrowth, defined as long-term stable reduction in regrowing hairs measured at 6, 9, and 12 months after treatment completion. The device features a 3.3 cm² treatment window, built-in skin sensor for contact detection, cooling function, and finger-switch activation powered by external adapter.

Technological characteristics

The subject device uses IPL at 610–1200 nm (±15 nm) with energy density of 2.18–7.27 J/cm² and output energy of 9–20 J (±20%), similar to the predicate. Key differences include pulse duration of 0.45 ms ± 0.2 ms (versus 8–12 ms for predicate) and power supply specifications (24V output versus 12V). Both devices have identical 3.3 cm² spot size, 5 intensity levels, software control, and require the same biocompatibility and electrical safety standards.

Test standards cited

Biocompatibility per ISO 10993-5 (cytotoxicity), ISO 10993-10 (irritation and sensitization), and ISO 10993-23 (irritation). Electrical safety and EMC per IEC 60601-1, IEC 60601-1-2, IEC 60601-1-11, and IEC 60601-2-83. Eye safety per IEC 62471. Software validation per moderate-level concern protocols.

Substantial equivalence argument

The device shares identical intended use, mode of action (IPL-based hair reduction), and output specifications (wavelength, energy density, spot size, intensity levels) as the predicate. Differences in pulse duration and power supply specifications are minor and do not affect safety or efficacy because the energy delivered to tissue and wavelength characteristics remain substantially similar. Biocompatibility, electrical safety, and eye safety testing all meet the same standards as the predicate, and performance data demonstrate comparable safety and effectiveness profiles for the intended OTC home-use application.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →